Matthew D. Slein

3.8k total citations
9 papers, 302 citations indexed

About

Matthew D. Slein is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Matthew D. Slein has authored 9 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Epidemiology. Recurrent topics in Matthew D. Slein's work include SARS-CoV-2 and COVID-19 Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Herpesvirus Infections and Treatments (2 papers). Matthew D. Slein is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Herpesvirus Infections and Treatments (2 papers). Matthew D. Slein collaborates with scholars based in United States, Germany and Netherlands. Matthew D. Slein's co-authors include Galit Alter, Carolin Loos, Stephanie Fischinger, Caroline Atyeo, Hendrik Streeck, Douglas A. Lauffenburger, Richelle C. Charles, Edward T. Ryan, John S. Burke and Sally Shin and has published in prestigious journals such as Cell, The Journal of Experimental Medicine and Science Translational Medicine.

In The Last Decade

Matthew D. Slein

8 papers receiving 300 citations

Peers

Matthew D. Slein
Tomer Zohar United States
Tamarand L. Darling United States
Annemarie Laumaea Canada
Elisabeth A. van Erp Netherlands
Chengzi I. Kaku United States
Ludivine Grzelak France
Kanika Vanshylla Germany
Robert C. Kauffman United States
Romain Gasser Canada
Helen E. Kent Australia
Tomer Zohar United States
Matthew D. Slein
Citations per year, relative to Matthew D. Slein Matthew D. Slein (= 1×) peers Tomer Zohar

Countries citing papers authored by Matthew D. Slein

Since Specialization
Citations

This map shows the geographic impact of Matthew D. Slein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Slein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Slein more than expected).

Fields of papers citing papers by Matthew D. Slein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Slein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Slein. The network helps show where Matthew D. Slein may publish in the future.

Co-authorship network of co-authors of Matthew D. Slein

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Slein. A scholar is included among the top collaborators of Matthew D. Slein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Slein. Matthew D. Slein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Slein, Matthew D., et al.. (2025). Eliminating interactions with the viral Fc receptor improves antibody-mediated protection against neonatal HSV infection in mice. Science Translational Medicine. 17(825). eadu8579–eadu8579.
2.
Slein, Matthew D., et al.. (2024). Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D. Cell Reports Medicine. 5(2). 101417–101417. 3 indexed citations
3.
Slein, Matthew D., et al.. (2022). Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity. The Journal of Experimental Medicine. 219(12). 12 indexed citations
4.
Karsten, Christina B., Yannic C. Bartsch, Sally Shin, et al.. (2022). Evolution of functional antibodies following acute Epstein-Barr virus infection. PLoS Pathogens. 18(9). e1010738–e1010738. 11 indexed citations
5.
Zohar, Tomer, Carolin Loos, Stephanie Fischinger, et al.. (2020). Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell. 183(6). 1508–1519.e12. 153 indexed citations
6.
Atyeo, Caroline, Matthew D. Slein, Stephanie Fischinger, et al.. (2020). Therapeutic Potential of SARS-CoV-2-Specific Monoclonal Antibody CR3022. SSRN Electronic Journal. 1 indexed citations
7.
Loos, Carolin, Caroline Atyeo, Stephanie Fischinger, et al.. (2020). Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity. mSphere. 5(5). 26 indexed citations
8.
Karsten, Christina B., Nickita Mehta, Sally Shin, et al.. (2019). A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis. Journal of Immunological Methods. 471. 46–56. 82 indexed citations
9.
Antoine, Alesia, David R. Howard, Matthew D. Slein, et al.. (2018). Coupling of Single Molecule, Long Read Sequencing with IMGT/HighV-QUEST Analysis Expedites Identification of SIV gp140-Specific Antibodies from scFv Phage Display Libraries. Frontiers in Immunology. 9. 329–329. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomer Zohar Breakdown of academic impact, for papers by Tamarand L. Darling Breakdown of academic impact, for papers by Annemarie Laumaea Breakdown of academic impact, for papers by Elisabeth A. van Erp Breakdown of academic impact, for papers by Chengzi I. Kaku Breakdown of academic impact, for papers by Ludivine Grzelak Breakdown of academic impact, for papers by Kanika Vanshylla Breakdown of academic impact, for papers by Robert C. Kauffman Breakdown of academic impact, for papers by Romain Gasser Breakdown of academic impact, for papers by Helen E. Kent
Rankless by CCL
2026